Development of a point of care device prototype for blood ammonia monitoring
Description
Hyperammonemia and associated neurological manifestations (hepatic encephalopathy) lead to coma and death and incur high costs. It affects 30-45% of cirrhotic patients. A novel portable point of care device based on pH-gradient polymersomes for daily monitoring of ammonia will alleviate the burdens.
Key Data
Projectlead
Deputy Projectlead
Project team
Project partners
Versantis AG
Project status
completed, 04/2022 - 01/2025
Institute/Centre
Institute of Computational Physics (ICP)
Funding partner
Innosuisse
Project budget
567'592 CHF
